date,title,source
Nov-05-18,Rubius Therapeutics to Announce Third Quarter 2018 Financial Results,GlobeNewswire
Nov-06-18,Rubius Therapeutics to Participate in Jefferies London Healthcare Conference,GlobeNewswire
Nov-13-18,Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress,GlobeNewswire
Nov-19-18,Rubius Therapeutics to Present at Evercore ISI HealthCONx Conference,GlobeNewswire
Dec-06-18,Cambridge's Moderna sets record with $604M IPO,American City Business Journals
Dec-17-18,Rubius Therapeutics Added to Nasdaq Biotechnology Index,GlobeNewswire
Dec-21-18,"Rubius Therapeutics, Inc. Secures $75 Million Loan Facility",GlobeNewswire
Dec-27-18,Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-07-19,Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Feb-19-19,Rubius Therapeutics to Participate at Upcoming Investor Conferences,GlobeNewswire
Feb-27-19,Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting,GlobeNewswire
Mar-11-19,"Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria",GlobeNewswire
Mar-19-19,Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results,GlobeNewswire
Mar-25-19,"How Many Insiders Bought Rubius Therapeutics, Inc. (NASDAQ:RUBY) Shares?",Simply Wall St.
Mar-25-19,Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer,GlobeNewswire
Mar-28-19,Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates,GlobeNewswire
Apr-02-19,Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting,GlobeNewswire
Apr-03-19,Rubius Therapeutics to Participate in Jefferies 6th Annual IO Cell Therapy Summit,GlobeNewswire
May-06-19,Rubius Therapeutics to Announce First Quarter 2019 Financial Results,GlobeNewswire
May-08-19,"In slow year for life science IPOs, this venture firm is making big money",American City Business Journals
May-15-19,Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress,GlobeNewswire
May-23-19,Preclinical biotech Stoke Therapeutics plans $86M IPO,American City Business Journals
May-28-19,Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference,GlobeNewswire
Jun-05-19,Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs,GlobeNewswire
